Search - tctmd.com

Displaying 301 - 320 of 516

Sort: Relevancy | Date

Presentation TCT 2017

When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies

Presenter: Robert A. Harrington, Kurt Huber, Michael D. Ezekowitz

November 01, 2017

Presentation TCT 2017

When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy?

Presenter: Robert A. Harrington, Kurt Huber, Roxana Mehran

November 01, 2017

Presentation TCT 2017

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: Robert A. Harrington, Kurt Huber, Michelle O'Donoghue

November 01, 2017

Presentation TCT 2017

Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More

Presenter: Robert A. Harrington, Kurt Huber, Didier Carrié

November 01, 2017

Presentation TCT 2017

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

Presenter: Robert A. Harrington, Kurt Huber, Freek W.A. Verheugt

November 01, 2017

Presentation TCT 2017

TCT 80: Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation and Flutter After PCI or CABG for Left Main Disease: Analysis From the EXCEL Trial

Presenter: Davide Capodanno, Tullio Palmerini, Ioanna Kosmidou

October 31, 2017

Presentation TCT 2017

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Presenter: Thomas H. Maloney, C. Michael Gibson

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Conference News ESC 2017

LAACS: Surgical Closure of the Left Atrial Appendage Shows Promise

Shelley Wood

September 04, 2017

News Conference News ESC 2017

ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach

Todd Neale

September 01, 2017

News Industry News

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

August 28, 2017

News Conference News ESC 2017

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

Todd Neale

August 27, 2017

News Daily News

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

Shelley Wood

August 15, 2017

Presentation LAA 2017

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Presenter: Gregg W. Stone

July 21, 2017

News Daily News

Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD

Yael L. Maxwell

June 20, 2017

Podcast TCTMD Talking Points

Episode 22: The A-fib and ACS Overlap

June 14, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

Presentation

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

May 23, 2017

Presentation EuroPCR 2017

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Presenter: Roberto Diletti

May 18, 2017

Advertisement

When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies

When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy?

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

TCT 80: Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation and Flutter After PCI or CABG for Left Main Disease: Analysis From the EXCEL Trial

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

LAACS: Surgical Closure of the Left Atrial Appendage Shows Promise

ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD

Episode 22: The A-fib and ACS Overlap

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content